Advancements in Neonatal Pharmacology Lecture Pack
Having a strong understanding of pharmacokinetics and how they are impacted by the development of the neonate is a crucial part of providing safe and effective care in the NICU. Particularly for preterm infants, medication use in the NICU is impacted by physiological immaturity and doses must constantly be adjusted to account for increases in weight and maturation of elimination pathways. This package focuses on providing current and evidence based information about pharmacology in the NICU, including a look at new and upcoming therapies. Join us to learn more about medication and breastmilk, advances in enteral nutrition, pharmacotherapy for hemodynamic instability, classic versus new and upcoming therapies for neonatal seizures, toxicities of common NICU medications and advanced post-operative pain management strategies.
Important Note: Please note that this package is available on the GOLD Learning CE website and was previously offered alongside the 2023 GOLD Neonatal Online Conference. If you have previously purchased and viewed this series of lectures, you will not be able to claim another accreditation certificate again.
*Only those registering for the main conference, or have registered for the main conference will have the ability to purchase this lecture pack. You will have the opportunity to purchase this add-on at the time of conference registration, or anytime afterwards (during the time of the conference).
- Quick View:
- Educational Credits
- Pricing
- Details
- REGISTER
Speakers & Presentations
-
MD, FRACP, PhDBiography Topic Info
Dr. Gayatri Jape is a consultant neonatal pediatrician with special interest in neonatal nutrition, probiotics, gut-brain-microbiota axis and long-term neuro-development. Dr. Jape leads the high-risk neonatal follow-up program for her tertiary referral institute. She is currently the chair for the Perinatal Society of Australia and New Zealand long-term outcomes sub-committee. Dr Jape is a Clinical Associate Professor at the School of Medicine University of Western Australia. Dr Jape is a reviewer for national and international medical journals.
Abstract:View Full Presentation InformationInfants admitted to neonatal intensive care units (very preterm and extremely preterm, term infants with HIE, term infants with surgical gut conditions) are at high-risk of suboptimal nutrition. They are at increased risk of poor growth and neurodevelopment in subsequent life. Improved enteral nutrition has been associated with better weight gain and improved neurocognitive outcomes in infancy , childhood and adolescence. This presentation aims to assess advances in enteral nutrition strategies across the different high-risk infant groups to highlight new research and optimize clinical care.
-
PharmD, BCPSBiography Topic Info
Jim Thigpen has been a pediatric clinical pharmacist for 30 years and is currently an associate professor of pharmacy at East Tennessee State University Bill Gatton College of Pharmacy. When he began his training at MUSC in Charleston, SC, they were investigating Survanta and he has been witness to and a participant in the evolving world of neonatology since. He has spoken at several neonatal nursing conferences over the years and enjoys helping other practitioners learn about and apply pharmacotherapy in this special population.
Abstract:View Full Presentation InformationThere are many causes of hemodynamic instability in the neonate, with up to half of very low birth weight (VLBW) infants exhibiting evidence of low cardiac output and poor myocardial contractility within the first 12 hours of life. Failure to appropriately identify and address the causes of hypotension can lead to dramatic consequences in this vulnerable population. Pharmacotherapy is employed to provide action at specific receptors that result in improved cardiac output, relaxation and vasodilation of smooth muscle, as well as specific effects on the kidneys. Although the common agents have been used for decades, there are new developments in therapy. Refinements on patient selection, managing expected side effects, and effective dosing and have continued to evolve.
-
PharmD, BCNSP, BCPPS, FASPENBiography Topic Info
M. Petrea Cober, PharmD, BCNSP, BCPPS, FASPEN, attended the University of Tennessee, College of Pharmacy in Memphis, Tennessee. She completed her PGY1 Pharmacy Residency at Penn State Milton S. Hershey Medical Center in Hershey, Pennsylvania, and her PGY2 Pharmacy Residency in Pediatrics at the University of Michigan Hospitals and Health System in Ann Arbor, Michigan. She is currently the Clinical Pharmacy Specialist - Neonatal Intensive Care Unit and PGY1 Residency Program Director at Akron Children's Hospital where she provides clinical services and precepts pharmacy students and PGY1 pharmacy residents. She is also a Professor in the Department of Pharmacy Practice at Northeast Ohio Medical University (NEOMED). Her didactic teaching is in the areas of pediatrics, women’s health, and nutrition. She was awarded the 2021 Stanley Serlick Award from the American Society for Parenteral and Enteral Nutrition (ASPEN) recognizing her contributions to parenteral nutrition safety and serves as the current Chair-elect of the ASPEN Parenteral Nutrition Safety Committee.
Topic: The Classics Versus New and Upcoming Therapies: Which is Better for Neonatal Seizures? - [View Abstract]
Abstract:View Full Presentation InformationThe lifetime risk of seizures is highest in the neonatal period. While the etiology of neonatal seizures is commonly the result of acute brain injury, other possibilities exist. Unfortunately, the need to treat neonatal seizures with anti-epileptic therapies or the timing and duration of therapeutic management is still vastly unknown. While phenobarbital has long been considered the mainstay of first-line medical therapy for neonatal seizures, newer agents are increasing in their popularity due to fewer side effects and concerns regarding potential neuronal apoptosis with phenobarbital. This presentation will discuss the etiology, need and timing for therapeutic management, compare and contrast various anti-epileptic therapies, and first-line, second-line, and therapies following initial failure for neonatal seizures.
-
PharmD, BCPPS, BCIDPBiography Topic Info
Pavel graduated from Purdue University with a BS in Medicinal Chemistry and Molecular Pharmacology and Doctor of Pharmacy. He completed his general residency at Parkview Medical Center and Pediatric Residency at University of Chicago. He is a neonatal ICU (NICU) and antimicrobial stewardship program clinical pharmacist at Nationwide Children's Hospital (NCH) in Columbus, OH. Pavel precepts pharmacy residents and students from several colleges of pharmacy while also serving as a preceptor to international pharmacy scholars from Europe, Africa, and Middle East. He is currently involved in a multicenter study to investigate barriers, enablers and opportunities for implementing neonatal antibiotic stewardship in public and private hospitals in South Africa. He is also involved in implementation of neonatal antimicrobial stewardship programs in several hospitals in Lebanon. Pavel is the principal investigator on the study evaluating interventions to reduce antibiotic use among surgical patients in the NICU: The NO-More-AntibioticS and Resistance in Surgery (NO-MAS-R-S) Study.
Abstract:Common medications used in the Neonatal Intensive Care Unit (NICU) are associated with severe Adverse Drug Effects (ADEs). These ADEs can easily be mistaken for other patient conditions, leading to under-recognition. ADEs can range from acute kidney injury to hepatic injury and even seizures. This discussion will focus on how common medications may affect the kidneys and liver, providing practical information on when to consider holding medications.View Full Presentation Information -
BS Pharm, PharmD, BCNSPBiography Topic Info
Teresa Puthoff, BS Pharm, PharmD, BCNSP received her professional degrees from the University of Cincinnati and The Ohio State University. She has over 30 years experience working in high risk delivery and referral centers. She currently works as an Advanced Practice Pharmacist in the NICU at Nationwide Children’s Hospital in Columbus Ohio. Her current professional passions are neonatal nutrition, developmental pharmacology, BPD, and analgesia and sedation management. She teaches PGY-1 and PGY-2 pharmacy residents as well as Neonatal Fellows in medicine, physical therapy and respiratory therapy. She has published on the use of regional analgesia in the NICU and is currently implementing the use of NCA and wound catheters for post op pain management as a part of ongoing efforts to reduce opioid and benzodiazepine use in the NICU.
Abstract:View Full Presentation InformationThere has been an evolution in knowledge regarding the consequences of untreated pain in the infant as well as the unintended long-term effects of providing systemic analgesics. Infants were often subjected to surgical procedures without analgesia until the landmark paper by Anand and Hickey demonstrated improved morbidity and mortality when proper anesthesia and analgesia were provided to infants undergoing surgical procedures. Early life stress and chronic pain has shown evidence of long-term adverse neurodevelopmental effects upto adulthood. An FDA Drug Safety Communication Alert advised practitioners that repeated or lengthy exposures to anesthetics and sedatives have the potential to have adverse effects on neurodevelopmental outcomes. Many anesthetics, benzodiazepines, and opiates act via NMDA (N-methyl-D-aspartate) receptor agonism, GABA (gamma amino butyric acid) agonism or both. Animal model studies have demonstrated neuro-apoptosis and subsequent cognitive impairments due to these drug-receptor interactions. Cumulative opioid exposure has been associated with adverse cognitive outcomes in former extremely low birth weight infants (ELBW). These concerns prompted many to pursue other pharmacologic modalities and surgical techniques to minimize the use of postoperative opioids. This lecture will discuss the use of Regional analgesia (RA) and Nurse Controlled Analgesia (NCA) in post operative infants in the NICU.
-
PhD, MRPharmSBiography Topic Info
In her employed life Wendy was a community pharmacist and also worked in doctor surgeries supporting cost effective, evidence-based prescribing.
Wendy left paid work to concentrate on writing Breastfeeding and Medication (Routledge 2nd edition 2018), developing information and training material on drugs in breastmilk as well as setting up her own website www.breastfeeding-and-medication. She has also published Breastfeeding for Dads and Grandmas (Praeclarus Press) and Why Mothers Medication Matters (Pinter and Martin). She is also co editor of a book to be published January 2020 called A guide to breastfeeding for medical professionals (Routledge).
Wendy is known for her work on providing a service on the compatibility of drugs in breastmilk and has been a breastfeeding peer supporter for 30 years. She is passionate that breastfeeding should be valued by all and that medication should not be a barrier. She has 3 daughters and 5 grandchildren. All her family seem as passionate about breastfeeding as she is and currently all 3 of her daughters are breastfeeding.
She was awarded a Points of Light award by the Prime Minister in 2018 and nominated for an MBE in the New Year's Honours List 2018 for services to mothers and babies. She received her award at Windsor Castle in May 2019 from Her Majesty the Queen.Abstract:View Full Presentation InformationFor optimal health, a baby born pre-term should be enabled to breastfeed as soon as possible or to receive expressed breastmilk from their birth mother. Where this isn't an option, donor breastmilk can be used. Breastfeeding a pre term or otherwise vulnerable baby in NICU is challenging, and where medications are involved there may be additional barriers. The baby may need medication to treat its own medical needs, the birth mother may also need medication and it is important to consider the risks of these passing through breastmilk. If the baby is to receive donor breastmilk then it is essential that the donor is not taking anything that might impact on the health of the recipient baby. In this presentation some of the barriers will be discussed along with discussion on how these may be overcome using the limited evidence base available.
Educational Credits
This Add-on Lecture Pack offers 6 hours of continuing education and is approved for 6 CME Prescribed Credits & 6 CERPs (1 L & 5 R). Nurse Contact Hours are applied for.
Advancements in Neonatal Pharmacology Add-on Purchase Details
Registration: Early Bird Registration is open. Register early & save!
Presentations: Start viewing from June 4 - August 30. (Until Sept. 20, 2024 for GOLD Annual Members)
Important Note: Please note that this package is available on the GOLD Learning CE website and was previously offered alongside the 2023 GOLD Neonatal Online Conference. If you have previously purchased and viewed this series of lectures, you will not be able to claim another accreditation certificate again.
Individual Advancements in Neonatal Pharmacology Add-on to Main Conference |
Group Advancements in Neonatal Pharmacology Add-on to Main Conference (per person) |
|||
|---|---|---|---|---|
| Early Bird | Regular | Early Bird | Regular | |
| ACountry Category | $90 | $110 | $80 | $100 |
| BCountry Category | $40 | $50 | $30 | $40 |
| C & DCountry Category | $20 | $25 | $15 | $20 |
| What is my Country Category?All Prices in $USD |
RegisterIndividual + Addon | RegisterGroup + Addon | ||
Add-on Purchase Details
- Group Registration: Pricing above is per person. Group rates for the Advancements in Neonatal Pharmacology Add-on Lecture Pack will be offered to members at the time of Main Conference Registration Only. As long as you have a group of 5+ members when you register for GOLD Neonatal Conference, your members will have the option to purchase the add-on. Not all group members are required to purchase the add-on to qualify for group discount pricing. Groups members may choose to purchase the add-on after their conference registration however they will be charged the individual rate at that time.
Registering for the add-on is easy! You will be prompted to select this add-on package when registering for GOLD Neonatal, selecting 'yes' if you wish to avail yourself of this special education. Log in details to access the lecture pack will be the same as when accessing GOLD Neonatal, during the same dates as the main conference.
Should you have any questions about this special package, please contact the Conference Manager through our contact form
Important! Test Your Technology...
1. Please read our Terms and Conditions
2. Take our Technology Test to ensure your computer meets the conference requirements
By registering, you agree to the terms and conditions and have confirmed that your computer is suitable.
If your computer does not pass the Technology Test it is not advisable to register until the possible problem is resolved. Click here for more information or contact us for technical support at [email protected].Registration Categories
As an international conference, we are sensitive to the fact that not all countries are economically equal. As breastfeeding advocates we recognise that people in these countries generally have the most need for this information and limited resources, which is why in addition to our standard registration options, this year we are offering a special registration fee for residents from countries that fall in Cat. B, C & D. The Categories are based of the World Bank Data. Please view our Reduced Rate Terms. Proof of residency maybe required.
Category A:
Andorra, Anguilla, Australia, Austria, Bahamas, Bahrain, Barbados, Belgium, Bermuda, Brunei, Canada, Cayman Islands, Chile, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Germany, Hong Kong, Hungary, Iceland, Ireland, Israel, Italy, Japan, Kuwait, Liechtenstein, Luxembourg, Macao, Malta, Monaco, Netherlands, New Zealand, Norway, Oman, Poland, Portugal, Qatar, San Marino, Saudi Arabia, Singapore, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, Trinidad and Tobago, United Arab Emirates, United Kingdom, United States of America. TOP
Category B:
Albania, Algeria, American Samoa, Antigua and Barbuda, Argentina, Azerbaijan, Belarus, Belize, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, China, Colombia, Costa Rica, Cuba, Curaçao, Dominica, Dominican Republic, Ecuador, Ecuador, Fiji, Grenada, Guatemala, Iran, Jamaica, Jordan, Kazakhstan, Kiribati, Latvia, Lebanon, Libya, Lithuania, FYR Macedonia, Malaysia, Maldives, Mauritius, Mexico, Montenegro, Palau, Peru, Puerto Rico, Romania, Russia, Serbia, Seychelles, South Africa, St. Kitts and Nevis, St. Lucia, St. Vincent & the Grenadines, Thailand, Turkey, Uruguay, Venezuela. TOP
Category C:
Angola, Armenia, Bhutan, Bolivia, Cape Verde, Côte d'Ivoire, Djibouti, East Timor, Egypt, El Salvador, Gabon, Georgia, Ghana, Guyana, Honduras, India, Indonesia, Iraq, Marshall Islands, Micronesia, Moldova, Mongolia, Morocco, Namibia, Nigeria, Pakistan, Panama, Paraguay, Philippines, Samoa, Sri Lanka, Suriname, Swaziland, Timor-Leste, Tunisia, Turkmenistan, Tuvalu, Ukraine, Uzbekistan, Vietnam. TOP
Category D:
Afghanistan, Bangladesh, Benin, Burkina Faso, Burundi, Cambodia, Cameroon, Central African Rep., Chad,Comoros, Democratic Republic of Congo, Equatorial Guinea, Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Haiti,Kenya, Kyrgyz Republic, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mozambique, Myanmar, Nauru, Nepal, Nicaragua, Niger, North Korea, Papua New Guinea, Rwanda, Sao Tomé and Principe, Senegal, Sierra Leone, Solomon Islands, Somalia, South Sudan, Sudan, Syrian Arab Republic, Tajikistan, Tanzania, Togo, Tonga, Uganda, Vanuatu, Yemen, Zambia, Zimbabwe. TOP
Dr. Speakers Full Name
Speaker Credentials
Annet Mulder first became interested in breastfeeding in the year 2000, when she became a mother for the first time. During and because of her own breastfeeding experiences, in 2002 she became a volunteer with the Dutch breastfeeding Organization and in 2008 sat for and passed the exam administered by the International Board of Lactation Consultant Examiners. As an International Board Certified Lactation Consultant, she now
Annet Mulder first became interested in breastfeeding in the year 2000, when she became a mother for the first time. During and because of her own breastfeeding experiences, in 2002 she became a volunteer with the Dutch breastfeeding Organization text text text text more name mulder first became interested in breastfeeding in the year 2000, when she became.
Dr. Speakers Full Name
Speaker Credentials